KNOWLEDGE ZONE – Page 41 – Cymbiotics Biopharma

Scientific Updates
September 8, 2025

Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study

Moderate-to-severe Atopic Dermatitis (AD) remains a challenging condition to treat, with existing…

Scientific Updates
September 7, 2025

Topical Niacinamide in Daily Skincare: A 3-Week Real-World Cosmetic Study

Niacinamide, also known as nicotinamide, is a form of vitamin B3 (part…

BLOGS
September 5, 2025

Beyond the Surface: Why Skin Is a Mirror of Internal Health

The skin is more than a physical shield against the outside world.…

Scientific Updates
September 4, 2025

Skin Microbiome Shifts in Dermatological Conditions and Therapeutic Prospects

The human skin serves as a crucial protective barrier, home to billions…